![Anders Månsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anders Månsson
Amministratore Delegato presso
ICONOVO AB
Patrimonio netto: 26 805 $ in data 31/05/2026
Profilo
Anders Månsson is currently Chief Executive Officer & Director at Mr. Månsson Business Development AB, Chief Executive Officer at Iconovo AB since 2025, Chairman at CanImGuide Therapeutics AB since 2017, and Independent Director at EQL Pharma AB since 2022.
Former roles include Chief Executive Officer at LIDDS AB from 2022 to 2023, Chief Business Officer & Deputy CEO at RhoVac AB in 2019, Chief Executive Officer at Phase Holographic Imaging AB from 2024 to 2025, Chief Executive Officer at RhoVac ApS from 2019 to 2025, Chief Executive Officer at Oncoinvent ASA (Old) from 2023 to 2024, Director at Respiratorius AB, Independent Director at Amniotics AB from 2021 to 2022, and Vice President & Head-Global Business Development at LEO Pharma A from 2011 to 2017.
Education includes an undergraduate degree from the University of Lund in 1997 and an MBA from Business School Lausanne in 2007.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
EQL PHARMA AB 0,03% | 31/03/2025 | 10.000 ( 0,03% ) | 26 805 $ | 31/05/2026 |
Posizioni attive di Anders Månsson
| Società | Posizione | Inizio |
|---|---|---|
| EQL PHARMA AB | Direttore/Membro del Consiglio | 23/08/2018 |
| ICONOVO AB | Amministratore Delegato | 31/10/2025 |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Presidente | 01/06/2017 |
Anders Månsson Business Development AB | Amministratore Delegato | - |
Precedenti posizioni note di Anders Månsson
| Società | Posizione | Fine |
|---|---|---|
RhoVac ApS
 RhoVac ApS Pharmaceuticals: MajorHealth Technology Manufactures medicines for cancers | Amministratore Delegato | 01/02/2025 |
| PHASE HOLOGRAPHIC IMAGING PHI AB | Amministratore Delegato | 01/02/2025 |
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Amministratore Delegato | 01/09/2024 |
| LIDDS AB | Amministratore Delegato | 01/08/2023 |
| AMNIOTICS AB | Amministratore Delegato | 01/01/2019 |
Formazione di Anders Månsson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
67
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
LEO Pharma A/S
 LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phase Holographic Imaging AB
 Phase Holographic Imaging AB BiotechnologyHealth Technology Develops and manufactures imaging microscopes and cell analyzers | Health Technology |
EQL Pharma AB
 EQL Pharma AB Pharmaceuticals: GenericHealth Technology Manufactures and distributes generic and specialty pharmaceutical products | Health Technology |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs to treat chronic obstructive pulmonary disease and asthma | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
LIDDS AB
 LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Business School Lausanne
 Business School Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
Iconovo AB
 Iconovo AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that manufactures and wholesales powder-based inhalation drugs and devices | Health Technology |
RhoVac ApS
RhoVac ApS Pharmaceuticals: MajorHealth Technology Manufactures medicines for cancers | Health Technology |
RhoVac AB
 RhoVac AB BiotechnologyHealth Technology Engages in the research and development of immunotherapy for therapeutic cancer vaccines | Health Technology |
Amniotics AB
 Amniotics AB BiotechnologyHealth Technology Develops stem cell-based therapeutics for the treatment of human diseases | Health Technology |
Anders Månsson Business Development AB |
